drugset / Trial / NCT04907149

Evaluation of Mass Balance and Absolute Bioavailability of GLPG3970

NCT04907149

Phase 1 Completed 6 enrolled Lakefront Biotherapeutics NV
Non-randomizedSequentialOpen-labelBasic science

Summary

A study in healthy male volunteers to assess how the radiolabelled test medicine is taken up and broken down by the body when given by short infusion into a vein and when given by the mouth in the form of a tablet and an oral solution.

Timeline

Start
2021-06-07
Primary completion
2021-07-12
Completion
2021-07-12

Drugs

EvaluationDrugModalityDoseRoute
Subject GLPG3970 Unknown Oral

Indications

No indication recorded.